tipo
- journal article
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project
Documento
- doi:10.3389/fimmu.2022.966416
- http://dx.doi.org/10.3389/fimmu.2022.966416
- http://dx.doi.org/10.3389/fimmu.2022.966416. eCollection 2022
- http://https://www.frontiersin.org/articles/10.3389/fimmu.2022.966416/full
- http://https://www.frontiersin.org/articles/10.3389/fimmu.2022.966416/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Immunology&id=966416
- http://https://www.frontiersin.org/articles/10.3389/fimmu.2022.966416/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Immunology&id=966416][doi:10.3389/fimmu.2022.966416
- https://pubmed.ncbi.nlm.nih.gov/36105814/
- https://www.frontiersin.org/articles/10.3389/fimmu.2022.966416/full
- Visão geral
- Pesquisas
- Identidade
- Informação adicional documento
- Outro
- Ver todos
Visão geral
autores
data de publicação
- 2022-01-01